Clinical Trials in New York State

Showing 5721-5740 of 17,167 trials

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

NCT01565694

The purpose of this study was to investigate a medicine for the treatment of symptoms and complications of neurogenic detrusor overactivity (NDO) in children and adolescents.

Neurogenic Detrusor Overactivity

Astellas Pharma Europe B.V.76 participantsStarted Aug 2012

Tarrytown, New York, United States • Cincinnati, Ohio, United States • Ghent, Belgium +18 more locations

COMPLETEDPhase 1/294 miles

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

NCT05364021

The objective of this study is to assess the safety, tolerability, efficacy, and pharmacokinetics of adjunctive therapy of LP352 in adults and adolescents with developmental and epileptic encephalopathies.

Developmental and Epileptic EncephalopathyDravet SyndromeLennox Gastaut Syndrome

Longboard Pharmaceuticals52 participantsStarted Mar 2022

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Downey, California, United States +31 more locations

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

Find Trials by Condition in New York State

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions

Pediatric Adenotonsillectomy Trial for Snoring

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers